Keywords: فارماکودینامیک; Metamizol; Tramadol; Tolerance; Pharmacokinetics; Pharmacodynamics;
مقالات ISI فارماکودینامیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فارماکودینامیک; thermosensitive; paclitaxel liposome; intratumoral retention; pharmacodynamics; tissue distribution; biodegradable polymers; cancer chemotherapy; controlled release; injectables; lymphatic transport; thermal gels;
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Animal model; Drug development;
Keywords: فارماکودینامیک; canagliflozin; India; pharmacodynamics; pharmacokinetics; safety;
Keywords: فارماکودینامیک; biosimilar; epoetin alfa; equivalence; erythropoietin; pharmacokinetics; pharmacodynamics;
Keywords: فارماکودینامیک; Pharmacodynamics; Cancer drug development; Proof-of-mechanism trials;
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Critical care; Sedatives; Analgesics; Renal; Hepatic; Dysfunction;
Keywords: فارماکودینامیک; CFA; complete Freund's adjuvant; FTB; full thickness burn; GFR; glomerular filtration rate; LA; local anesthetics; NMDA; N-methyl-d-aspartic acid; OIH; opioid-induced hyperalgesia; PK; pharmacokinetics; PD; pharmacodynamics; PTSD; post-traumatic stress di
Keywords: فارماکودینامیک; Arterial spin labeling; Cerebral blood flow; Intranasal; Oxytocin; Pharmacodynamics; Resting state;
Keywords: فارماکودینامیک; dosing; drug; MRSA; obesity; pharmacodynamics; pharmacokinetics;
Keywords: فارماکودینامیک; Antiepileptics; Antidepressants; Antipsychotics; Drug interactions; Pharmacodynamics; Pharmacokinetics
Keywords: فارماکودینامیک; obese; omarigliptin; pharmacodynamics; pharmacokinetics; type 2 diabetes mellitus;
Keywords: فارماکودینامیک; Insulin therapy; Diabetes; Pharmacodynamics; Regular insulin;
Keywords: فارماکودینامیک; antibiotics; antifungal agents; burns; pharmacokinetics; pharmacodynamics;
Keywords: فارماکودینامیک; Metabolite pharmacokinetics; UD-CG 212; Inodilator; Feline; Pharmacodynamics;
Keywords: فارماکودینامیک; antibiotic; dosing; exposure; pharmacodynamics; pharmacokinetics;
Keywords: فارماکودینامیک; diuresis; hydrochlorothiazide; pharmacodynamics; torasemide;
Keywords: فارماکودینامیک; Microdialysis; Distribution; Tissue; Antibiotics; Pharmacokinetics; Pharmacodynamics;
Keywords: فارماکودینامیک; Cocaine; Benzoylecgonine; Plasma; Oral fluid; Pharmacodynamics; Pharmacokinetics;
Keywords: فارماکودینامیک; ACPP; activated cell-penetrating peptide; AFM; atomic force microscopy; AN; angiopeptin; ANP; NP modified with ACPP peptide; APE-1; apurinic endonuclease-1; AU; gold; AUC; area under the curve; AUNP; gold nanoparticles; AUNS; gold nanoshells; BAT; brain a
Keywords: فارماکودینامیک; LTα; lymphotoxin α; eEFD; enhanced embryo-fetal development; GD; gestation days; NHP; non-human primate; TNF; tumor necrosis factor; TNFR; TNF receptor; FDCs; follicular dendritic cells; HEVs; high endothelial venules; RA; rheumatoid arthritis; mAb; mon
Keywords: فارماکودینامیک; Hepatotoxic drugs; liver disease; pharmacodynamics; pharmacokinetics; prescribing
Keywords: فارماکودینامیک; AKI; Acute kidney injury; GFR; Glomerular filtration rates; IV; Intravenous; OAT; Organic acid transporter; PD; Pharmacodynamics; PK; Pharmacokinetic; PO; Oral; pRIFLE; Pediatric modified RIFLE criteria; Scr; Serum creatinine;
Keywords: فارماکودینامیک; pharmacokinetics; pharmacodynamics; TIVA; propofol; remifentanil;
Keywords: فارماکودینامیک; pharmacokinetics; pharmacodynamics; drug distribution; target-controlled infusion; TCI; drug interaction;
Keywords: فارماکودینامیک; Lacosamide; Sleep; Pharmacodynamics; Tolerability
Keywords: فارماکودینامیک; antiinfectives; clinical pharmacokinetics; doripenem; Monte Carlo; pediatric; pharmacodynamics
Keywords: فارماکودینامیک; ECM; extracellular matrix; PAD; peripheral arterial disease; PD; pharmacodynamics; PK; pharmacokinetics; VEGF; vascular endothelial growth factor; Mechanistic computational model; Systems pharmacology; Drug development; Pharmacokinetics; Pharmacodynamics;
Keywords: فارماکودینامیک; fentanyl; metabolism; neonate; pharmacokinetics; pharmacodynamics
Keywords: فارماکودینامیک; Dexmedetomidine; Pharmacokinetics; Pharmacodynamics; Hypoalbuminemia; Abdominal surgery; Thoracic surgery
Keywords: فارماکودینامیک; biosimilar; biologic; guidelines; clinical practice; inflammatory disorders; innovator; reference product; interchangeability; comparability; immunogenicity; extrapolation; pharmacokinetics; pharmacodynamics; pharmacovigilance; regulations; naming; labeli
Keywords: فارماکودینامیک; drug interaction; isobole; pharmacodynamics; response surface model;
Keywords: فارماکودینامیک; Biosimilar; biologic; reference product; chronic inflammatory diseases; clinical studies, comparability; immunogenicity, extrapolation; pharmacokinetics; pharmacodynamics; regulatory guidances; study design; safety;
Keywords: فارماکودینامیک; Intraspecific competition; Pharmacodynamics; Reproductive success; Semi-natural enclosures; SSRI; Toxicity assessment;
Keywords: فارماکودینامیک; empagliflozin; once daily; pharmacodynamics; pharmacokinetic properties; twice daily;
Keywords: فارماکودینامیک; cancer chemotherapy; pharmacodynamics; drug effects; efflux pumps; cell lines;
Keywords: فارماکودینامیک; Hemodialysis; rivaroxaban; anticoagulant; anti-FXa activity; atrial fibrillation; stroke; end-stage renal disease (ESRD); area under the curve (AUC); pharmacokinetics; pharmacodynamics; dose finding; dose adjustment; dosing guideline;
Keywords: فارماکودینامیک; cortisol; HPA axis; ketamine; pharmacodynamics; pharmacokinetics; stress;
Keywords: فارماکودینامیک; Edivoxetine; DHPG; Pharmacokinetic; Pharmacodynamics; Atomoxetine;
Keywords: فارماکودینامیک; Timolol maleate; Deacetylated gellan gum; Ocular drug delivery system; Liposomal-ion sensitivity in situ gel; Pharmacodynamics;
Keywords: فارماکودینامیک; Triamcinolone acetonide (PubChem CID: 6436); Indocyanine green (PubChem CID: 11967809); Saline (PubChem CID: 5234); Lipopolysaccharide (PubChem CID: 11970143); Haemotoxylin (PubChem CID: 10603); Eosin (PubChem CID: 173745); Formalin (PubChem CID: 712); Pa
Keywords: فارماکودینامیک; combination; gabapentin enacarbil; morphine; pharmacodynamics; pharmacokinetics;
Keywords: فارماکودینامیک; FPG; HbA1c; Taspoglutide; Glucagon-like peptide-1; Pharmacodynamics; Meta-analysis
Keywords: فارماکودینامیک; Folic acid receptor; Long-acting nanoformulated antiretroviral therapy; Human immunodeficiency virus type one; Pharmacokinetics; Pharmacodynamics; Non-obese diabetic severe combined immunodeficient mice;
Keywords: فارماکودینامیک; Clopidogrel; Pharmacodynamics; Antiplatelet aggregation; CYP2C19; CYP3A5; PON1; Genetic polymorphism
Keywords: فارماکودینامیک; canagliflozin; pharmacodynamics; pharmacokinetics; safety; sodium-glucose cotransporter 2 inhibitor;
Keywords: فارماکودینامیک; Exenatide extended-release; Model based meta-analysis; Pharmacokinetics; Pharmacodynamics; Dosing regimens
Keywords: فارماکودینامیک; Inhalation products; Pharmacokinetics; Pharmacodynamics; Bioequivalence; Therapeutic equivalence; Clinical endpoint studies
Keywords: فارماکودینامیک; ADME; clearance; disposition; drug safety; hepatocytes; IVIVEs; isolated perfused liver; PKPD; pharmacokinetics; pharmacodynamics;
Keywords: فارماکودینامیک; hydromorphone; ketamine; drug delivery; microparticles; intrathecal; pharmacodynamics; poly(lactic-co-glycolicacid)(PLGA); rat model of chemotherapy-induced peripheral neuropathy (CIPN rats); cancer chemotherapy; intractable cancer-related pain;